(Q30567434)

20 August 2017

Impact of C-peptide preservation on metabolic and clinical outcomes in the Diabetes Control and Complications Trial (English)

1 reference

20 August 2017

1

1 reference

20 August 2017

3

Jerry P Palmer

1 reference

20 August 2017

Paula McGee

2

1 reference

20 August 2017

DCCT/EDIC Research Group

series ordinal

4

1 reference

20 August 2017

language of work or name

English

0 references

publication date

2 October 2013

1 reference

20 August 2017

1 reference

20 August 2017

63

1 reference

20 August 2017

2

1 reference

20 August 2017

739-748

1 reference

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported

20 August 2017

start time

30 August 2021

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

C-peptide in the natural history of type 1 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3900540

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3900540

C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3900540

Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3900540

Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). The DCCT Research Group

26 November 2018

1 reference

12 December 2020

Effect of intensive diabetes treatment on nerve conduction in the Diabetes Control and Complications Trial

1 reference

12 December 2020

Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

Correlation between minimal secretory capacity of pancreatic beta-cells and stability of diabetic control

1 reference

12 December 2020

Identifiers

DOI

10.2337/DB13-0881

1 reference

20 August 2017

1 reference

20 August 2017

PubMed publication ID

24089509

1 reference